Note 4 - Fair Value Measurement and Fair Value of Financial Instruments - Changes in Contingent Consideration and Warrant Liabilities (Details) - Fair Value, Inputs, Level 3 [Member] - Contingent Consideration [Member] - USD ($) $ in Thousands |
3 Months Ended | ||
|---|---|---|---|
Jun. 30, 2026 |
Mar. 31, 2026 |
Dec. 31, 2025 |
|
| Balance | $ 8 | $ 12 | $ 102 |
| Additions | 0 | 0 | 0 |
| Payments, exercises or expirations | 0 | 0 | 0 |
| Adjustment to fair value | (2) | (4) | (90) |
| Balance | $ 6 | $ 8 | $ 12 |
| X | ||||||||||
- Definition Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|